Skip to main content

Find Clinical Trials

Home
Conditions
Esophageal Diseases

Clinical trial condition

Esophageal Diseases

Explore clinical trials studying Esophageal Diseases. Study availability and eligibility vary by location and protocol.

3,519 public trials 714 recruiting studies

Refine in advanced search Browse all conditions

Esophageal Diseases trial results

Completed

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

NCT00810485

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +7 more
Locations: Little Rock, Arizona, United States

Tucson, Arizona, United States

Anaheim, California, United States

San Diego, California, United States

View all 40 locations

View Trial Details

Completed

Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease

NCT01132638

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: Investigational site Belo Horizonte/MG, Brazil

Investigational site Curitiba/PR, Brazil

Investigational site Goiânia/GO, Brazil

Investigational site Porto Alegre/RS, Brazil

View Trial Details

Completed

Endobronchial Ultrasound (EBUS) for Nodal Staging in Esophageal Cancer

NCT01038544

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations: Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada

View Trial Details

Completed

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

NCT00012363

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +17 more
Locations: MBCCOP - Gulf Coast Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix, Arizona, United States

Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States

View all 96 locations

View Trial Details

Completed

Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

NCT00445861

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Kantonsspital - St. Gallen Sankt Gallen, Switzerland

Klinik Stephanshorn Sankt Gallen, Switzerland

View Trial Details

Completed

Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

NCT00238407

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Hirslanden Klinik Aarau Aarau, Switzerland

Saint Claraspital AG Basel, Switzerland

Universitaetsspital-Basel Basel, Switzerland

Inselspital Bern Bern, Switzerland

View Trial Details

Completed

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

NCT00072033

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Kantonspital Aarau Aarau, Switzerland

Universitaetsspital-Basel Basel, Switzerland

Inselspital Bern Bern, Switzerland

Spitaeler Chur AG Chur, Switzerland

View Trial Details

Completed

Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.

NCT00551473

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
Locations: GSK Investigational Site Randwick, Sydney, New South Wales, Australia

View Trial Details

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus

NCT00002984

Conditions: Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States

View Trial Details

Completed

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

NCT01605305

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Not specified

View Trial Details